Resultados: 79

The impact of COPD on the private healthcare system in Brazil: an economic analysis

Nascimento, Oliver Augusto; Saturnino, Luciana Tarbes Mattana; Santos, Felipe Moares dos; Silva, Danielle Oliveira da; Gazzotti, Mariana Rodrigues; Martins, Franco Chies; Gomes, Ana Luisa Bessa Bacellar; Viana, Karynna Pimentel; Afonso-Cristancho, Rafael; Rodrigues, Claudia Soares.

J. bras. econ. saúde (Impr.); 15 (1), 2023

Objective: To assess healthcare resource utilization and hospitalization costs of patients with chronic obstructive pulmonary disease (COPD) exacerbations in the Brazilian private healthcare system. Methods: A retrospective cohort study, considering data from an administrative database of a private compa...

Doença Pulmonar Obstrutiva Crônica, Custos e Análise de Custo, Saúde Suplementar

Texto completo

Innovative mechanisms of pre-marketing authorization access for rare diseases in Brazil: a case study of pabinafusp-alfa for mucopolysaccharidosis type II

Falavigna, Maicon; Migliavaca, Celina Borges; Tanaka, Elio; Santos, Marcos.

J. bras. econ. saúde (Impr.); 15 (1), 2023

Patients with rare diseases frequently face unmet medical needs due to the high costs, lengthy development times, and slow approval processes for new treatments. This case study discusses innovative access alternatives for rare diseases in Brazil, focusing on early access to pabinafusp-alfa for mucopolys...

Acesso a Medicamentos Essenciais e Tecnologias em Saúde, Doenças Raras, Mucopolissacaridose II

Texto completo

Flebite associada ao cateter venoso periférico em cardiologia: incidência, fatores de risco e custos associados

Ribeiro, Sílvia; Valente, Sara; Sousa, Salomé Sobral; Lopes, Marisa; Abreu, Nuno; Alves, Eduardo.

J. bras. econ. saúde (Impr.); 15 (1), 2023

Objetivo: Determinar a incidência de flebite, fatores de risco associados e custos diretos de tratamento. Métodos: Estudo descritivo, correlacional, com análise de custo direto. Utilizaram-se dados da documentação dos enfermeiros entre janeiro 2019 e agosto 2021. Resultados: Incluíram-se 2.374 pess...

Flebite, Cateterismo Periférico, Cateteres, Cuidados de Enfermagem, Custos e Análise de Custo

Texto completo

Participação plurissocial para aumentar a inclusão e a assertividade nas tomadas de decisão em saúde relacionadas a tratamentos da osteoporose

Papler, Pérola G; Rocha, Bruna; Cortez, Eliane; Mensor, Luciana L.

J. bras. econ. saúde (Impr.); 15 (1), 2023

Embora as fraturas por fragilidade sejam importantes detratoras de qualidade de vida relacionada à saúde, aumentando a morbimortalidade e acarretando alto impacto clínico, psicossocial e econômico, elas são pouco valorizadas e negligenciadas por médicos e até mesmo por pacientes. Além disso, os c...

Osteoporose, Teoria da Decisão, Fraturas por Osteoporose

Texto completo

Direct costs associated with lupus nephritis management in the Private Healthcare System in Brazil: an expert panel perspective

Silva, Danielle O; David, Nathalie; Kano, Bruce Y; Kashiura, Diego; Monticielo, Odirlei A; Hayata, André; Gazzotti, Mariana R; Bernardino, Graziela.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Objective: To estimate direct medical costs of lupus nephritis (LN) in the Brazilian private healthcare system. Methods: An expert panel of five specialists were convened to discuss health resource usage in LN patient management. The discussion included diagnosis, treatment, and disease monitoring, inclu...

Nefrite Lúpica, Custos e Análise de Custo, Terapia de Imunossupressão, Transplante de Rim, Diálise

Texto completo

Cost comparison of dupilumab and omalizumab for the treatment of severe allergic asthma patients from the Brazilian private healthcare system perspective

Magro, Frederico José Bighetti; Barbosa, Aline; Taminato, Alexandre; Migliavaca, Celina Borges; Federico, Priscila; Tebyriçá, Renata Nahuys; Cançado, Jose Eduardo D; Giavina-Bianchi, Pedro; Falavigna, Maicon.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Objective: To compare the costs of dupilumab and omalizumab for treating severe allergic asthma patients from the perspective of the Brazilian private healthcare system. Methods: Using clinical and demographic inputs from the literature, we simulated a cohort of 5,000 severe allergic asthma patients and ...

Asma, Custos e Análise de Custo, Omalizumab

Texto completo

Comment on: Immunotherapy-based firstline treatment of intermediate- and poorrisk advanced renal cell carcinoma: number needed to treat and cost of preventing an event from the perspective of the Brazilian private healthcare system

Leonart, Letícia Paula; Riveros, Bruno Salgado; Berlinski, Felipe; Rego, Maria Aparecida do Carmo.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Imunoterapia, Carcinoma de Células Renais

Texto completo

Analysis of epidemiological and economic data of hemophilia A patients in Brazil

Sarmento, Túlio Tadeu Rocha; Picoli, Renato Mantelli; Renni, Marília; Sato-Kuwabara, Yukie; Mata, Verônica Elizabeth.

J. bras. econ. saúde (Impr.); 14 (3), 2022

Objective: To describe the annual medical direct costs per hemophilia A (HA) patient in the Brazilian public healthcare system (SUS) and to understand and describe the patients’ hospital journey, demographical characteristics, and the procedures in the. Methods: This retrospective analysis of DataSUS d...

Epidemiologia, Hemofilia A, Efeitos Psicossociais da Doença

Texto completo

The cost of total hip replacement: a multicentric TDABC comparison in Brazil

Zanotto, Bruna; Etges, Ana Paula; Sugo, Arthur; Cardoso, Ricardo; Picado, Celso; Nunes, Altacilio; Cruz, Luciane; Lima, Ana Flávia.

J. bras. econ. saúde (Impr.); 14 (Suplemento 2), 2022

Objective: Monitoring costs is critical in searching for a more effective healthcare system. This study aimed to comprehend the care pathway and measure the costs associated with hip replacement surgeries in different hospitals in Brazil. Methods: The time-driven activity-based costing method was applied...

Custos e Análise de Custo, Artroplastia de Quadril, Gastos em Saúde

Texto completo

Analysis of micro-costing through the Time-Driven Activity-Based Costing (TDABC) method in viscosupplementation procedures in different application regimens

Ramos, Leonardo; Cohen, Moisés; Araújo, Denizar.

J. bras. econ. saúde (Impr.); 14 (Suplemento 2), 2022

Objective: To evaluate the micro-costing of viscosupplementation procedures compared to different infiltration regimens. Methods: This study compared, through the Time-Driven ActivityBased Costing method, the micro-costing of these different application regimens using national cost averages as a basis fo...

Alocação de Custos, Osteoartrite, Viscossuplementação

Texto completo